“Roflumilast Cream 0.15% in Patients with Atopic Dermatitis: Individual Patient Response from the Pooled INTEGUMENT-1 and INTEGUMENT-2 Phase 3 Trials”, J of Skin, vol. 8, no. 2, p. s372, Mar. 2024, doi: 10.25251/skin.8.supp.372.